Polyprenyl Immunostimulant™ clinical trials
VetImmune® is a distributor and does not run clinical trials. Because many customers ask questions about the trials, we are listing past, current, and planned clinical trials that involve Polyprenyl Immunostimulant™.
All clinical trials and are run by Sass & Sass, Inc., the manufacturer, and other research groups. You may request more detailed information from Sass & Sass, Inc. by email.
Please note that under their ethics in clinical trials guidelines, Sass & Sass, Inc. believes that study animals should not be euthanized but should be provided a chance through adoption and be treated like any owned pet. Sass & Sass, Inc. does not purposely infect animals with fatal diseases and does not support any research that does.
Polyprenyl Immunostimulant™ past, current, and planned clinical trials.
• Double-blinded, placebo-controlled clinical trials of the efficacy of Polyprenyl Immunostimulant™ in feline rhinotracheitis.University of Tennessee-Knoxville. Dr. A.M. Legendre, Principal Investigator.
Status: Completed.
Results published at http://journal.frontiersin.org/article/10.3389/fvets.2017.00024/full
• Field study of efficiency of Polyprenyl Immunostimulant™ in naturally occurring cases of non-effusive FIP. University of Tennessee-Knoxville. Dr. A.M. Legendre, Principal Investigator.
Status: Completed.
Results published at https://www.frontiersin.org/articles/10.3389/fvets.2017.00007/full
• Field safety study of Polyprenyl Immunostimulant™. University of Tennessee-Knoxville. Dr. A.M. Legendre, Principal Investigator.
Status: Completed.
Results published at http://journal.frontiersin.org/article/10.3389/fvets.2017.00024/full
• Clinical safety study of ocular topical application of Polyprenyl Immunostimulant™. University of Tennessee-Knoxville. Dr. D. VanHorn Hendrix, Principal Investigator.
Status: Completed.
Results presented at the meeting of the American College of Veterinary Ophthalmologists in 2017.
• Field efficacy study of Polyprenyl Immunostimulant™ in herpetic keratitis. University of Tennessee-Knoxville. Dr. D. VanHorn Hendrix, Principal Investigator.
Status: Will open soon. Eligibility: ophthalmology specialists only. The enrollment information will follow.
• Case studies in cats with chronic rhinotracheitis treated with Polyprenyl Immunostimulant™.
Status: On-going.
Published Research
Legendre AM, et al. Front Vet Sci, February 14, 2017
Legendre AM, Bartges JW. 2009 JFMS, 11, 624-626
Legendre AM, et al. Front Vet Sci February 27. 2017